For supplement brands, the better choice depends on product positioning, dosage form, serving size, taste, cost, and label claims
Tirzepatide is a dual-agonist that activates both GLP-1 and GIP receptors
MHRA and NICE Approval Pathway Explained Before reaching NHS patients, retatrutide must first obtain MHRA marketing authorisation, then undergo a NICE technology appraisal
Estrogen moderates blood pressure through three key mechanisms: dilation of blood vessels, inhibition of the renin-angiotensin system in the kidneys and moderation of SNS stimulation
Body Balance Medical is a physical clinic not a telehealth platform, not a subscription service
While medical weight management is a rapidly growing field, many providers find the most success by combining GLP-1 services with aesthetic injectables